Pliant Therapeutics (PLRX) Capital Expenditures (2019 - 2025)
Pliant Therapeutics (PLRX) reported Capital Expenditures of -$262000.0 for Q4 2025, down 225.36% year-over-year from $209000.0 in Q4 2024, and down 200.0% quarter-over-quarter from $262000.0 in Q3 2025.
Pliant Therapeutics (PLRX) Capital Expenditures (2019 - 2025) Analysis & Trends
Pliant Therapeutics (PLRX) has 7 years of Capital Expenditures data on file, last reported at -$262000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at -$262000.0, down 225.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$150000.0 (down 105.73% YoY), and the FY2025 annual result was $112000.0, down 97.09% from the prior year.
- Capital Expenditures eased to -$262000.0 in Q4 2025 per PLRX's latest filing, from $262000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.4 million in Q3 2024 and troughed at -$1.6 million in Q4 2022.
- A 5-year average of $246900.0 and a median of $186000.0 in 2023 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 3537.23% in 2024 and fell as far as 310.95% in 2024.
- A 5-year view of Capital Expenditures shows it stood at -$1.3 million in 2021, then slipped by 22.24% to -$1.6 million in 2022, then surged by 103.83% to $61000.0 in 2023, then surged by 242.62% to $209000.0 in 2024, then slumped by 225.36% to -$262000.0 in 2025.
- Business Quant data shows PLRX's Capital Expenditures at -$262000.0 in Q4 2025, $262000.0 in Q3 2025, and -$150000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -262,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 61,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Sep 30, 2023 | 94,000.00 |